Listed medtech Artrya is seeking $80 million from investors to accelerate its commercial entry into the US market after gaining a key regulatory approval for its AI-powered healthcare tool.
09/09/2025 - 15:39
Perth medtech Artrya taps investors for $80m
09/09/2025 - 15:39
